Cargando…
Frequency and Correlates of Mild Cognitive Impairment in Myasthenia Gravis
Background: Antibodies against acetylcholine receptors (AChRs) can also target nicotinic AChRs that are present throughout the central nervous system, thus leading to cognitive dysfunctions in patients with myasthenia gravis (MG). However, the presence of cognitive impairment in MG is controversial,...
Autores principales: | Iacono, Salvatore, Di Stefano, Vincenzo, Costa, Vanessa, Schirò, Giuseppe, Lupica, Antonino, Maggio, Bruna, Norata, Davide, Pignolo, Antonia, Brighina, Filippo, Monastero, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953757/ https://www.ncbi.nlm.nih.gov/pubmed/36831713 http://dx.doi.org/10.3390/brainsci13020170 |
Ejemplares similares
-
Impact of COVID-19 in AChR Myasthenia Gravis and the Safety of Vaccines: Data from an Italian Cohort
por: Lupica, Antonino, et al.
Publicado: (2022) -
Advances on Cellular Clonotypic Immunity in Amyotrophic Lateral Sclerosis
por: Schirò, Giuseppe, et al.
Publicado: (2022) -
Clinical and Neurophysiological Follow-Up of Chronic Inflammatory Demyelinating Polyneuropathy Patients Treated with Subcutaneous Immunoglobulins: A Real-Life Single Center Study
por: Alonge, Paolo, et al.
Publicado: (2022) -
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and Shadows
por: Vinciguerra, Claudia, et al.
Publicado: (2023) -
Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis
por: Norata, Davide, et al.
Publicado: (2023)